Joy Bessenger
Financieel Directeur/CFO bij TRELLUS HEALTH PLC
Actieve functies van Joy Bessenger
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRELLUS HEALTH PLC | Financieel Directeur/CFO | 18-09-2023 | - |
Loopbaan van Joy Bessenger
Eerdere bekende functies van Joy Bessenger
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMV INC. | Investor Relations Contact | 01-09-2021 | 11-06-2022 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Public Communications Contact | 26-06-2009 | - |
Opleiding van Joy Bessenger
| University of South Florida | Undergraduate Degree |
Statistieken
Internationaal
| IJsland | 2 |
| Canada | 2 |
| Verenigde Staten | 2 |
Operationeel
| Public Communications Contact | 1 |
| Investor Relations Contact | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IMV INC. | Health Technology |
| TRELLUS HEALTH PLC | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Beurs
- Insiders
- Joy Bessenger
- Ervaring